Neostigmine Cooper (Neostigmine Methylsulfate)

Neostigmine methylsulfate, the active ingredient in Neostigmine Cooper, is an anticholinesterase presented as an injectable solution for intramuscular, intravenous, and subcutaneous use. It is employed to reverse neuromuscular blockade, to improve muscle strength in myasthenia gravis, and to stimulate gastrointestinal motility after surgery.

GNH USA supplies Neostigmine Cooper as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Neostigmine methylsulfate acts on the cholinergic neuromuscular system and is used in several clinical settings.

- Reversal of neuromuscular blockade: restores muscle function after general anaesthesia. - Myasthenia gravis: increases skeletal‑muscle strength in patients with autoimmune weakness. - Postoperative ileus: promotes intestinal motility to reduce postoperative bowel paralysis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis. - Increased salivation: excess oral secretions. - Sweating: generalized hyperhidrosis. - Abdominal cramps: gastrointestinal discomfort. - Muscle fasciculations: brief, involuntary twitches.

Serious or Rare Side Effects: - Bradycardia: significant slowing of heart rate. - Bronchospasm: narrowing of airways causing breathing difficulty. - Severe hypotension: marked drop in blood pressure. - Cholinergic crisis: excessive cholinergic activity leading to muscle weakness. - Allergic reactions: rash, urticaria, or anaphylaxis. - Seizures: rare neurologic events.

Careful assessment and monitoring are required before and during therapy.

- Cardiac monitoring: patients with known heart block or arrhythmias should be observed. - Respiratory function: watch for bronchospasm or increased secretions. - Renal/hepatic impairment: dose may need adjustment in severe dysfunction. - Concomitant anticholinergic drugs: may diminish therapeutic effect. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at ambient temperature: keep in original container, protect from moisture and light.

Neostigmine methylsulfate can alter the activity of several other medicines.

Major Interactions (Avoid): - Non‑depolarizing neuromuscular blockers: potentiation of muscle relaxation. - Beta‑blockers: enhanced bradycardia risk. - Organophosphate exposure: additive cholinergic toxicity.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: reduced efficacy of Neostigmine. - Inhaled anesthetics: additive effects on neuromuscular transmission. - Diuretics: potential electrolyte disturbances that may affect response.